Education
About Us
Working with TipRanks
Follow Us
Alto Neuroscience, Inc. (ANRO)
NYSE:ANRO
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 210.00K |
| Gross Profit | $ -502.00K | $ -373.00K | $ -342.00K | $ 65.00K |
| Operating Income | $ -68.61M | $ -37.81M | $ -29.19M | $ -12.06M |
| EBITDA | $ -68.61M | $ -34.56M | $ -27.37M | $ -9.04M |
| Net Income | $ -61.43M | $ -36.30M | $ -27.71M | $ -9.19M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 168.23M | $ 82.55M | $ 48.34M | $ 25.70M |
| Total Assets | $ 177.54M | $ 86.63M | $ 50.85M | $ 28.79M |
| Total Debt | $ 16.94M | $ 9.99M | $ 82.11M | $ 38.16M |
| Net Debt | $ -151.28M | $ -72.56M | $ 33.76M | $ 12.46M |
| Total Liabilities | $ 26.08M | $ 158.30M | $ 89.26M | $ 41.27M |
| Stockholders' Equity | $ 151.46M | $ -71.67M | $ -38.41M | $ -12.48M |
| Cash Flow | ||||
| Free Cash Flow | $ -49.50M | $ -33.92M | $ -21.13M | $ -9.94M |
| Operating Cash Flow | $ -47.42M | $ -33.45M | $ -20.39M | $ -9.26M |
| Investing Cash Flow | $ -2.08M | $ -470.00K | $ -732.00K | $ -680.00K |
| Financing Cash Flow | $ 135.69M | $ 68.13M | $ 43.79M | $ 31.69M |